1. Home
  2. SNSE vs QTI Comparison

SNSE vs QTI Comparison

Compare SNSE & QTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNSE
  • QTI
  • Stock Information
  • Founded
  • SNSE 2005
  • QTI 2012
  • Country
  • SNSE United States
  • QTI United States
  • Employees
  • SNSE N/A
  • QTI N/A
  • Industry
  • SNSE Biotechnology: Pharmaceutical Preparations
  • QTI
  • Sector
  • SNSE Health Care
  • QTI
  • Exchange
  • SNSE Nasdaq
  • QTI NYSE
  • Market Cap
  • SNSE 12.3M
  • QTI 8.7M
  • IPO Year
  • SNSE 2021
  • QTI N/A
  • Fundamental
  • Price
  • SNSE $0.48
  • QTI $0.39
  • Analyst Decision
  • SNSE Strong Buy
  • QTI
  • Analyst Count
  • SNSE 3
  • QTI 0
  • Target Price
  • SNSE $4.33
  • QTI N/A
  • AVG Volume (30 Days)
  • SNSE 272.7K
  • QTI 175.3K
  • Earning Date
  • SNSE 11-14-2024
  • QTI 11-13-2024
  • Dividend Yield
  • SNSE N/A
  • QTI N/A
  • EPS Growth
  • SNSE N/A
  • QTI N/A
  • EPS
  • SNSE N/A
  • QTI N/A
  • Revenue
  • SNSE N/A
  • QTI $4,037,118.00
  • Revenue This Year
  • SNSE N/A
  • QTI N/A
  • Revenue Next Year
  • SNSE N/A
  • QTI N/A
  • P/E Ratio
  • SNSE N/A
  • QTI N/A
  • Revenue Growth
  • SNSE N/A
  • QTI 10884.16
  • 52 Week Low
  • SNSE $0.38
  • QTI $0.35
  • 52 Week High
  • SNSE $1.94
  • QTI $14.40
  • Technical
  • Relative Strength Index (RSI)
  • SNSE 45.51
  • QTI 37.74
  • Support Level
  • SNSE $0.42
  • QTI $0.35
  • Resistance Level
  • SNSE $0.50
  • QTI $0.44
  • Average True Range (ATR)
  • SNSE 0.04
  • QTI 0.05
  • MACD
  • SNSE 0.00
  • QTI -0.01
  • Stochastic Oscillator
  • SNSE 44.44
  • QTI 13.30

About SNSE Sensei Biotherapeutics Inc.

Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing highly selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101, SNS-102, SNS-103, SNS-20.

About QTI QT IMAGING HOLDINGS INC

QT Imaging Holdings Inc is engaged in the research, development and commercialization of an automated breast imaging system producing high-resolution transmission ultrasound images.

Share on Social Networks: